NovoCure (NVCR) Gross Margin Growth (1y) (2015 - 2026)
NovoCure (NVCR) Gross Margin Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 128.00 |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 448.00 |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 60.00 |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 305.00 |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | -6.00 |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 391.00 |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 153.00 |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -4,158.00 |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 69.00 |
| 10 | NovoCure | 2.05 Bn | 1.61 Bn | 142.48 Mn | 372.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 372.00 |
| Mar 31, 2026 | 249.00 |
| Dec 31, 2025 | -343.00 |
| Sep 30, 2025 | -394.00 |
| Jun 30, 2025 | -307.00 |
| Mar 31, 2025 | -53.00 |
| Dec 31, 2024 | 358.00 |
| Sep 30, 2024 | 240.00 |
| Jun 30, 2024 | 394.00 |
| Mar 31, 2024 | -9.00 |
| Dec 31, 2023 | -184.00 |
| Sep 30, 2023 | -250.00 |
| Jun 30, 2023 | -675.00 |
| Mar 31, 2023 | -408.00 |
| Dec 31, 2022 | -21.00 |
| Sep 30, 2022 | -10.00 |
| Jun 30, 2022 | 119.00 |
| Mar 31, 2022 | -57.00 |
| Dec 31, 2021 | -274.00 |
| Sep 30, 2021 | -120.00 |